Sai Life Sciences Limited (NSE:SAILIFE)
1,801.20
-127.60 (-6.62%)
Nov 16, 2026, 2:50 PM IST
Sai Life Sciences Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Sai Life Sciences stock has a consensus rating of "Buy" and an average price target of ₹1,876. The average 1-year stock price forecast is 4.16% higher than the current stock price, while the lowest is ₹1,580 (-12.28%) and the highest is ₹2,186 (+21.36%).
Price Target: ₹1,876 (+4.16%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 12, 2026.
Analyst Ratings
The average analyst rating for Sai Life Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹1,270 → ₹1,610 | Buy | Maintains | ₹1,270 → ₹1,610 | -10.62% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
27.58B
from 21.92B
Increased by 25.80%
Revenue Next Year
32.44B
from 27.58B
Increased by 17.63%
EPS This Year
20.98
from 16.76
Increased by 25.18%
EPS Next Year
26.26
from 20.98
Increased by 25.16%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.